Projects

Mgr. Anna Zemančíková, PhD.

National

Current
  • The role of sex hormones in the a1AMPK- mediated vascular protection during the development of the metabolic syndrome
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • Cardiovascular protection mediated by alpha 1 AMPK against metabolic syndrome-mediated endothelial dysfunction - identifying new risk factors
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • Zofenopril and erucin, H2S releasing coumpounds, in therapy of cardiovascular disorder in experimental model of obesity and 2 type diabetes
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
Finished
  • Mesenteric perivascular fat and its specific role in regulation of intestinal circulation in rats with different feeding regimens
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2023
  • Nitroso-sulphide signal pathway - novel regulator vasoactive effects in different types of arterial hypertension
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • New perspectives in the treatment of cardiovascular complications associated with COVID-19
    Program: SRDA
    Duration: 16. 9. 2020 – 31. 12. 2021
  • Relationship between body adiposity and functional properties of arteries in rat
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
  • New regulatory effects of nitric oxide and their role in the development of essential hypertension
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • The role of perivascular adipose tissue in the regulation of vascular tone in rats with cardiovascular dysfunction
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Effect of aging on the endothelial function in experimental hypertension
    Program: Other projects
    Duration: 17. 4. 2014 – 17. 4. 2017
  • -
    Program: Other projects
    Duration: 19. 7. 2013 – 31. 12. 2015
  • Characterization of cardiovascular and metabolic changes in fructose-induced metabolic syndrome in the rat
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2014
  • Effect of antioxidants on blood pressure and manifestation of sympathetic activity in conduit arteries in rats with experimental hypertension
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
  • Pharmacological treatment of hypertension in early stage of its development
    Program: VEGA
    Duration: 1. 1. 2006 – 1. 12. 2008
Employees